ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,024 | +6.8% | 19,075 | +38.2% | 0.08% | -23.8% |
| Q2 2023 | $636,779 | +19.7% | 13,804 | +7.4% | 0.10% | -0.9% |
| Q3 2022 | $532,000 | +110.3% | 12,852 | +268.4% | 0.11% | +211.8% |
| Q1 2022 | $253,000 | -69.3% | 3,489 | -59.7% | 0.03% | -70.7% |
| Q2 2021 | $825,000 | +31.0% | 8,651 | -41.3% | 0.12% | +251.5% |
| Q4 2019 | $630,000 | -64.5% | 14,748 | -64.5% | 0.03% | -64.9% |
| Q3 2019 | $1,777,000 | +5126.5% | 41,548 | +13749.3% | 0.09% | +308.7% |
| Q4 2015 | $34,000 | -99.4% | 300 | +200.0% | 0.02% | +475.0% |
| Q3 2014 | $5,660,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |